UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
iShares MSCI USA Small-Cap ETF
MSML
$272M
| $1.64M | ﹤0.01% |
21,740
-658
| -3% | -$46.8K |
2014 Q4
46 quarters
|
|
5252
CALL
Cencora
COR
$63.7B
| $1.64M | ﹤0.01% |
5,800
-5,400
| -48% | -$1.56M |
2024 Q1
9 quarters
|
|
5253
Ironwood Pharmaceuticals
IRWD
$725M
| $1.64M | ﹤0.01% |
389,529
-543,696
| -58% | -$2.1M |
2014 Q4
46 quarters
|
|
5254
Anixa Biosciences
ANIX
$110M
| $1.64M | ﹤0.01% |
585,430
+33,793
| +6% | +$94K |
2015 Q3
43 quarters
|
|
5255
Forward Industries Inc
FWDI
$435M
| $1.64M | ﹤0.01% |
388,013
+265,188
| +216% | +$1.18M |
2024 Q4
6 quarters
|
|
5256
DELISTED
Stellar Bancorp
STEL
| $1.63M | ﹤0.01% |
41,489
-370,177
| -90% | -$13.9M |
2019 Q2
28 quarters
|
|
|
DYNC
5257
DELISTED
Dynamix Corp
DYNC
| $1.63M | ﹤0.01% |
151,177
+133,280
| +745% | +$1.43M |
2025 Q3
3 quarters
|
|
5258
ICL Group
ICL
$6.04B
| $1.63M | ﹤0.01% |
326,814
-219,235
| -40% | -$1.25M |
2014 Q4
46 quarters
|
|
|
UROY
5259
Uranium Royalty Corp
UROY
$1.16B
| $1.63M | ﹤0.01% |
584,664
+281,930
| +93% | +$989K |
2021 Q2
20 quarters
|
|
5260
Upstream Bio Inc
UPB
$177M
| $1.62M | ﹤0.01% |
234,714
+3,460
| +1% | +$29K |
2024 Q4
6 quarters
|
|
5261
Maravai LifeSciences
MRVI
$1.12B
| $1.62M | ﹤0.01% |
260,265
+68,467
| +36% | +$296K |
2020 Q4
22 quarters
|
|
5262
PUT
PureCycle Technologies
PCT
$336M
| $1.62M | ﹤0.01% |
+200,000
| New | +$1.79M |
2026 Q2
0 quarters
|
|
5263
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $1.62M | ﹤0.01% |
36,055
+1,724
| +5% | +$92.6K |
2026 Q1
1 quarter
|
|
5264
Invesco Building & Construction ETF
PKB
$248M
| $1.62M | ﹤0.01% |
14,455
-1,746
| -11% | -$184K |
2014 Q4
46 quarters
|
|
5265
VanEck Digital Transformation ETF
DAPP
$206M
| $1.62M | ﹤0.01% |
83,552
+48,427
| +138% | +$970K |
2026 Q1
1 quarter
|
|
5266
Employers Holdings
EIG
$830M
| $1.62M | ﹤0.01% |
32,076
-115,195
| -78% | -$5.05M |
2014 Q4
46 quarters
|
|
5267
Global X SuperIncome Preferred ETF
SPFF
$131M
| $1.62M | ﹤0.01% |
172,563
+6,595
| +4% | +$62K |
2016 Q3
39 quarters
|
|
5268
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$140M
| $1.62M | ﹤0.01% |
16,574
-573
| -3% | -$56.3K |
2014 Q4
46 quarters
|
|
5269
Defiance Daily Target 2X Long IONQ ETF
IONX
$88.7M
| $1.61M | ﹤0.01% |
31,716
| – | – |
2025 Q4
2 quarters
|
|
5270
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$723M
| $1.61M | ﹤0.01% |
98,876
+3,782
| +4% | +$60.4K |
2014 Q4
46 quarters
|
|
5271
Anavex Life Sciences
AVXL
$107M
| $1.61M | ﹤0.01% |
620,374
+50,418
| +9% | +$149K |
2015 Q4
42 quarters
|
|
5272
PicS N.V.
PICS
$889M
| $1.6M | ﹤0.01% |
150,952
-277,615
| -65% | -$3.15M |
2026 Q1
1 quarter
|
|
5273
ProShares UltraPro Short S&P 500
SPXU
$478M
| $1.6M | ﹤0.01% |
43,238
+10,780
| +33% | +$446K |
2024 Q1
9 quarters
|
|
5274
Republic Bancorp
RBCAA
$1.78B
| $1.6M | ﹤0.01% |
17,655
+4,820
| +38% | +$382K |
2014 Q4
46 quarters
|
|
5275
PUT
Upstart Holdings
UPST
$2.17B
| $1.59M | ﹤0.01% |
45,000
-330,000
| -88% | -$10.2M |
2025 Q3
3 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.